Aurobindo Pharma

USFDA pulls up Eugia for manufacturing lapses, data accuracy at Hyderabad plant

In a warning letter to Eugia Pharma Specialities CEO Yugandhar Puvvala, the US health regulator pointed out that the company failed to ensure the accuracy of data for production and process simulation.

25 August 2024, 09:53 IST

USFDA pulls up Eugia for manufacturing lapses, data accuracy at Hyderabad plant

25 August 2024, 09:53 IST

Aurobindo Pharma arm gets warning letter from USFDA for formulations unit in Telangana

Earlier in May, the company had stated that Unit-III, a formulation manufacturing facility of Eugia Pharma Specialities Ltd., a wholly-owned subsidiary, received Official Action Indicated (OAI) status by the US Food and Drug Administration (USFDA).

16 August 2024, 10:19 IST

Aurobindo Pharma arm gets warning letter from USFDA for formulations unit in Telangana

16 August 2024, 10:19 IST

Lupin, Eugia recall products from US market: US Food and Drug Administration

As per the latest Enforcement Report issued by the US Food and Drug Administration (USFDA), a US-based unit of Lupin is recalling a medication used to treat bacterial infections.

23 June 2024, 06:29 IST

Lupin, Eugia recall products from US market: US Food and Drug Administration

23 June 2024, 06:29 IST

Aurobindo Pharma commissions four plants in Andhra Pradesh including Pen-G facility

The Rs 2,400 crore Pen-G plant is expected to start trial production in April and commercial production in a couple of months

01 April 2024, 07:53 IST

Aurobindo Pharma commissions four plants in Andhra Pradesh including Pen-G facility

01 April 2024, 07:53 IST

Aurobindo Pharma gets USFDA approval for generic antifungal injection

The approval is for Posaconazole injection of 300 mg/16.7 ml, single-dose vial.

27 December 2023, 10:27 IST

Aurobindo Pharma gets USFDA approval for generic antifungal injection

27 December 2023, 10:27 IST

Aurobindo Pharma Q1 profit up 10 pc at Rs 571 cr

Revenue from operations rose to Rs 6,850.5 crore from Rs 6,236 crore in the year-ago period, the Hyderabad-based firm said in a statement.

12 August 2023, 15:22 IST

Aurobindo Pharma Q1 profit up 10 pc at Rs 571 cr

12 August 2023, 15:22 IST

US FDA finds multiple faults at Aurobindo Pharma plant

Auditors uncovered 'deficient' manufacturing equipment cleaning and storage controls during a visit last month to an Aurobindo Pharma Ltd.

30 June 2023, 03:35 IST

US FDA finds multiple faults at India’s second-biggest drugmaker Aurobindo Pharma

US FDA finds multiple faults at Aurobindo Pharma plant

30 June 2023, 03:35 IST

Aurobindo Pharma stocks at 52-week low after Q2 results

Revenue from operations of Aurobindo Pharma also declined to Rs 5,739 crore in the September quarter as against Rs 5,942 crore in the year-ago period

14 November 2022, 07:14 IST

Aurobindo Pharma shares tumble nearly 7%, hit 52-week low after Q2 earnings

Aurobindo Pharma stocks at 52-week low after Q2 results

14 November 2022, 07:14 IST

Delhi liquor scam: Aurobindo Pharma head arrested by ED

Benoy Babu of Pernod Ricard has also been arrested; the two will be produced before a special PMLA court in Delhi

10 November 2022, 12:32 IST

Aurobindo Pharma's Sharath Reddy arrested in Delhi liquor policy case

Delhi liquor scam: Aurobindo Pharma head arrested by ED

10 November 2022, 12:32 IST

Aurobindo recalls products in US market over mfg lapses

The affected lot of the medication, which is used to treat high blood pressure, has been manufactured in India

08 November 2022, 05:26 IST

Aurobindo units recall products in US market over manufacturing lapses

Aurobindo recalls products in US market over mfg lapses

08 November 2022, 05:26 IST